Kemi Chems Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-07-2024
- Paid Up Capital ₹ 3.20 M
as on 03-07-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.50 Cr
as on 03-07-2024
- Satisfied Charges ₹ 1.17 Cr
as on 03-07-2024
- Revenue 292.13%
(FY 2020)
- Profit 94.93%
(FY 2020)
- Ebitda -1846.31%
(FY 2020)
- Net Worth 4.49%
(FY 2020)
- Total Assets 24.88%
(FY 2020)
About Kemi Chems
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.20 M.
The company currently has active open charges totaling ₹18.50 Cr. The company has closed loans amounting to ₹1.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bharat Choudhary and Karan Choudhary serve as directors at the Company.
- CIN/LLPIN
U51397DL2004PTC125044
- Company No.
125044
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kemi Chems?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bharat Choudhary | Director | 08-Mar-2004 | Current |
Karan Choudhary | Director | 24-Apr-2006 | Current |
Financial Performance of Kemi Chems.
Kemi Chems Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 292.13% increase. The company also saw a substantial improvement in profitability, with a 94.93% increase in profit. The company's net worth moved up by a moderate rise of 4.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kemi Chems?
In 2020, Kemi Chems had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Alfa Solvents Private LimitedActive 17 years 4 months
Bharat Choudhary and Karan Choudhary are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 25 May 2022 | ₹18.50 Cr | Open |
Bank Of Baroda Creation Date: 26 Aug 2009 | ₹0.40 M | Satisfied |
Bank Of Baroda Creation Date: 31 Oct 2008 | ₹1.10 Cr | Satisfied |
How Many Employees Work at Kemi Chems?
Unlock and access historical data on people associated with Kemi Chems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kemi Chems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kemi Chems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.